Healthcare Realty Trust (NYSE:HR)‘s stock had its “equal weight” rating reissued by stock analysts at Capital One Financial in a research note issued to investors on Wednesday, Zacks.com reports.
A number of other equities analysts have also recently commented on HR. Citigroup lifted their target price on shares of Healthcare Realty Trust from $29.00 to $30.00 and gave the stock a “neutral” rating in a research report on Thursday, July 2nd. Wells Fargo & Co reiterated a “hold” rating on shares of Healthcare Realty Trust in a research report on Tuesday, April 28th. Raymond James decreased their target price on shares of Healthcare Realty Trust from $38.00 to $34.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Finally, Zacks Investment Research upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Thursday. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $32.00.
NYSE HR opened at $29.09 on Wednesday. The company has a market capitalization of $3.89 billion, a P/E ratio of 35.91 and a beta of 0.54. The company has a fifty day moving average of $29.33 and a 200-day moving average of $31.44. Healthcare Realty Trust has a 52-week low of $24.10 and a 52-week high of $37.97. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.60 and a current ratio of 1.60.
Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Wednesday, August 5th. The real estate investment trust reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.15. Healthcare Realty Trust had a net margin of 22.38% and a return on equity of 5.91%. As a group, analysts forecast that Healthcare Realty Trust will post 1.62 EPS for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the business. Alliancebernstein L.P. boosted its stake in shares of Healthcare Realty Trust by 28.1% during the 1st quarter. Alliancebernstein L.P. now owns 498,903 shares of the real estate investment trust’s stock valued at $13,934,000 after purchasing an additional 109,540 shares in the last quarter. APG Asset Management N.V. bought a new stake in shares of Healthcare Realty Trust during the 1st quarter valued at about $243,000. AlphaCrest Capital Management LLC boosted its stake in shares of Healthcare Realty Trust by 227.5% during the 1st quarter. AlphaCrest Capital Management LLC now owns 37,982 shares of the real estate investment trust’s stock valued at $1,061,000 after purchasing an additional 26,386 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Healthcare Realty Trust by 38.6% during the 1st quarter. BNP Paribas Arbitrage SA now owns 56,934 shares of the real estate investment trust’s stock valued at $1,590,000 after purchasing an additional 15,844 shares in the last quarter. Finally, Scout Investments Inc. boosted its stake in shares of Healthcare Realty Trust by 26.8% during the 2nd quarter. Scout Investments Inc. now owns 643,797 shares of the real estate investment trust’s stock valued at $18,857,000 after purchasing an additional 136,057 shares in the last quarter. Hedge funds and other institutional investors own 95.79% of the company’s stock.
About Healthcare Realty Trust
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of December 31, 2018, the Company owned 199 real estate properties in 27 states totaling 14.8 million square feet and was valued at approximately $4.9 billion.
Featured Story: What is a SEC Filing?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
12 Cheap Dividend Stocks to Buy Today
While COVID-19 was a suckerpunch to the stock market earlier in the year, the stock market is roaring back. The Dow is hovering around 27,000 and the S&P 500 is trading near 3,200. S&P 500 stocks are trading at nearly 23 times their annual earnings, still well above historical norms.
At the same time, interest rates are near all-time lows (and probably dipping even lower). 10-year Treasuries are yielding just 0.9% and collectively S&P 500 stocks are yielding under 2%. Some investors think that it’s too challenging to find safe and affordable securities that pay 4%, 5%, and even 6% yields.
Searching for yield isn’t easy in an environment where historically high asset prices and stimulus from the Fed have driven down yields. This doesn’t leave many options for investors looking for retirement income or a decent dividend yield on their stocks, but there are a handful of cheap dividend stocks to buy that are still yielding 3-6%.
Let’s review some of the best cheap dividend stocks in the market today in this slideshow.
View the “12 Cheap Dividend Stocks to Buy Today”.